ConforMIS Stock News

BILLERICA, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the fourth quarter and year ended December 31, 2020.

Shares of ConforMIS (NASDAQ: CFMS) traded up as high as 37% in Tuesday's pre-market trading session. The company released a press release stating that the Therapeutic Goods Administration, part of the

On Wednesday, March 03, Conformis (NASDAQ:CFMS) will release its latest earnings report. Decipher the announcement with Benzinga's help.

CFMS stock is jumping as Conformis preps to introduce a knee replacement system in Australia. Here's what you should know.

The stock price of ConforMIS Inc (NASDAQ: CFMS) is trading at over 50% pre-market as of 4:48 AM ET. This is why it happened.

The iTotal® PS total knee replacement system is designed so that its patient-specific implants fit the unique size and shape of each patient's knee, and provide optimal stability throughout the full

BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an offering

BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis int

BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical device

Conformis (CFMS) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief Exe

Cordera™ Match Hip System combines the proven Cordera™ hip stem with Conformis' state-of-the-art, personalized pre-operative plans and patient-specific instruments. Cordera™ Match Hip System c

BILLERICA, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Bart Lagae as its new VP, International Sales & Marketing.

Conformis's (CFMS) CEO Mark Augusti on Q3 2020 Results - Earnings Call Transcript

ConforMIS (CFMS) delivered earnings and revenue surprises of 25.00% and 0.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?